Little information is available on factors directly controlling the osteoclast or the molecular events responsible for osteoclast formation and bone resorption. The cell and molecular biological characterization of the osteoclast has been severely hampered by the inability to isolate large numbers of osteoclasts or osteoclast precursors and the unavailability of established osteoclastic cell lines. The proposed studies are designed to allow the establishment of cell lines that express the full differentiated phenotype of osteoclasts from osteoclast tumors formed in transgenic mice. These cell lines will then be used to address questions concerning the effects of estrogen and other osteotropic factors on osteoclast function. The proposed strategy involves directing the expression of an oncogene, such as SV40 Tantigen, specifically or preferentially to osteoclast cells using the regulatory regions of the genes encoding tartrate resistant acid phosphatase (TRAP) and the calcitonin receptor (CTR). Transgenic mice expressing these hybrid transgenes are expected to develop bone tumors of osteoclast origin, or possibly immortalized osteoclast precursors in the blood, spleen or bone marrow. These immortalized cells will be placed in culture and cell lines will be established. The cell lines will be extensively characterized to determine the extent to which they resemble osteoclasts or osteoclast precursors and to test their ability to differentiate in culture. In addition, cell lines will be derived from both male and female mice to allow a comparison of phenotype. Finally, since estrogen may affect the formation and activity of osteoclasts, studies will be undertaken to determine the effects of estrogen on the growth and differentiation of these cells and on their ability to resorb bone. In addition, estrogen will be administered to the transgenic mice to determine if the pattern of mononuclear or multinucleated osteoclastic cells is altered in vivo. Based on the success of the transgenic mouse approach for deriving established differentiated cell lines representing other rare cell types, we are hopeful that the proposed studies will lead to the development of established cell lines representing osteoclasts or osteoclast precursors. Such cell lines would provide a novel system for in vitro analysis of important questions concerning the role of estrogen and other osteotropic factors or accessory cells in regulating osteoclast function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR041336-03
Application #
3161728
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1991-09-30
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Ishizuka, Hisako; García-Palacios, Verónica; Lu, Ganwei et al. (2011) ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J Bone Miner Res 26:169-81
Tondelli, Barbara; Blair, Harry C; Guerrini, Matteo et al. (2009) Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse. Am J Pathol 174:727-35
Garcia-Palacios, Veronica; Chung, Ho Yeon; Choi, Sun Jin et al. (2007) Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1. Bone 40:316-22
Palacios, Veronica Garcia; Chung, Ho Yeon; Choi, Sun Jin et al. (2006) Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression. Ann N Y Acad Sci 1068:240-3
Lu, Ganwei; Maeda, Hidefumi; Reddy, Sakamuri V et al. (2006) Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem 281:30542-50
Rao, Hongwei; Lu, Ganwei; Kajiya, Hiroshi et al. (2006) Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function. J Bone Miner Res 21:1657-65
Xing, Lianping; Boyce, Brendan F (2005) Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun 328:709-20
Roodman, G David (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655-64
Oba, Yasuo; Chung, Ho Yeon; Choi, Sun Jin et al. (2003) Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor. J Bone Miner Res 18:1332-41
Choi, S J; Oba, Y; Gazitt, Y et al. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 108:1833-41

Showing the most recent 10 out of 38 publications